{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:24:56Z","timestamp":1777533896035,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1038\/sj.npp.1300879","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T15:38:41Z","timestamp":1124984321000},"page":"897-903","source":"Crossref","is-referenced-by-count":27,"title":["Corticosterone Modulates Auditory Gating in Mouse"],"prefix":"10.1038","volume":"31","author":[{"given":"Christina R","family":"Maxwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S","family":"Ehrlichman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Gettes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight L","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Kanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Karp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"BF1300879_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/0006-3223(86)90244-1","volume":"21","author":"LE Adler","year":"1986","unstructured":"Adler LE, Rose G, Freedman R (1986). Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol Psychiatry 21: 787\u2013798.","journal-title":"Biol Psychiatry"},{"key":"BF1300879_CR2","first-page":"588","volume":"294","author":"L Arborelius","year":"2000","unstructured":"Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ (2000). Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. J Pharmacol Exp Ther 294: 588\u2013597.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300879_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s002130000528","volume":"152","author":"CH Ashton","year":"2000","unstructured":"Ashton CH, Lunn B, Marsh VR, Young AH (2000). Subchronic hydrocortisone treatment alters auditory evoked potentials in normal subjects. Psychopharmacology (Berl) 152: 87\u201392.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300879_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000118489","volume":"20","author":"J Born","year":"1989","unstructured":"Born J, Hitzler V, Pietrowsky R, Pauschinger P, Fehm HL (1989). Influences of cortisol on auditory evoked potentials (AEPs) and mood in humans. Neuropsychobiology 20: 145\u2013151.","journal-title":"Neuropsychobiology"},{"key":"BF1300879_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0165-1781(96)02919-8","volume":"69","author":"N Boutros","year":"1997","unstructured":"Boutros N, Nasrallah H, Leighty R, Torello M, Tueting P, Olson S (1997). Auditory evoked potentials, clinical vs research applications. Psychiatry Res 69: 183\u2013195.","journal-title":"Psychiatry Res"},{"key":"BF1300879_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-8760(98)00040-3","volume":"31","author":"TW Budd","year":"1998","unstructured":"Budd TW, Barry RJ, Gordon E, Rennie C, Michie PT (1998). Decrement of the N1 auditory event-related potential with stimulus repetition: habituation vs refractoriness. Int J Psychophysiol 31: 51\u201368.","journal-title":"Int J Psychophysiol"},{"key":"BF1300879_CR7","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1023\/B:NERE.0000023605.68408.fb","volume":"29","author":"PM Connolly","year":"2004","unstructured":"Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T et al (2004). The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res 29: 1179\u20131188.","journal-title":"Neurochem Res"},{"key":"BF1300879_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2003.08.035","volume":"992","author":"PM Connolly","year":"2003","unstructured":"Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J et al (2003). Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA\/2J and DBA\/2Hsd inbred mouse substrains. Brain Res 992: 85\u201395.","journal-title":"Brain Res"},{"key":"BF1300879_CR9","first-page":"823","volume":"273","author":"GK DeKrey","year":"1995","unstructured":"DeKrey GK, Kerkvliet NI (1995). Effects of exogenous corticosterone treatment on alloantigen-specific cytotoxic T lymphocyte activity in mice. J Pharmacol Exp Ther 273: 823\u2013829.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300879_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0006-8993(02)03612-0","volume":"957","author":"CL Ehlers","year":"2002","unstructured":"Ehlers CL, Somes C (2002). Long latency event-related potentials in mice: effects of stimulus characteristics and strain. Brain Res 957: 117\u2013128.","journal-title":"Brain Res"},{"key":"BF1300879_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0378-5955(93)90207-H","volume":"65","author":"LC Erway","year":"1993","unstructured":"Erway LC, Willott JF, Archer JR, Harrison DE (1993). Genetics of age-related hearing loss in mice: I. Inbred and F1 hybrid strains. Hear Res 65: 125\u2013132.","journal-title":"Hear Res"},{"key":"BF1300879_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0920-9964(94)90019-1","volume":"11","author":"RJ Erwin","year":"1994","unstructured":"Erwin RJ, Shtasel D, Gur RE (1994). Effects of medication history on midlatency auditory evoked responses in schizophrenia. Schizophr Res 11: 251\u2013258.","journal-title":"Schizophr Res"},{"key":"BF1300879_CR13","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1523\/JNEUROSCI.0231-05.2005","volume":"25","author":"WN Frankel","year":"2005","unstructured":"Frankel WN, Beyer B, Maxwell CR, Pretel S, Letts VA, Siegel SJ (2005). Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H\/He and backcross mice. J Neurosci 25: 3452\u20133458.","journal-title":"J Neurosci"},{"key":"BF1300879_CR14","volume-title":"Meta-Analysis in Social Research","author":"GV Glass","year":"1981","unstructured":"Glass GV, McGaw B, Smith ML (1981). Meta-Analysis in Social Research. Sage: Newbury Park, CA."},{"key":"BF1300879_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1525-5050(03)00148-3","volume":"4","author":"JJ Halford","year":"2003","unstructured":"Halford JJ (2003). Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy. Epilepsy Behav 4: 375\u2013385.","journal-title":"Epilepsy Behav"},{"key":"BF1300879_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00005053-197904000-00006","volume":"167","author":"RC Hall","year":"1979","unstructured":"Hall RC, Popkin MK, Stickney SK, Gardner ER (1979). Presentation of the steroid psychoses. J Nerv Ment Dis 167: 229\u2013236.","journal-title":"J Nerv Ment Dis"},{"key":"BF1300879_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0165-0327(00)00353-0","volume":"62","author":"U Hegerl","year":"2001","unstructured":"Hegerl U, Gallinat J, Juckel G (2001). Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62: 93\u2013100.","journal-title":"J Affect Disord"},{"key":"BF1300879_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00491982","volume":"65","author":"DS Janowsky","year":"1979","unstructured":"Janowsky DS, Risch C (1979). Amphetamine psychosis and psychotic symptoms. Psychopharmacology (Berl) 65: 73\u201377.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300879_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1388-2457(99)00313-2","volume":"111","author":"DC Javitt","year":"2000","unstructured":"Javitt DC, Jayachandra M, Lindsley RW, Specht CM, Schroeder CE (2000). Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clin Neurophysiol 111: 833\u2013836.","journal-title":"Clin Neurophysiol"},{"key":"BF1300879_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-1781(97)03091-6","volume":"70","author":"Y Jin","year":"1997","unstructured":"Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, Bunney Jr WE (1997). Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 70: 71\u201381.","journal-title":"Psychiatry Res"},{"key":"BF1300879_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0013-4694(85)91035-1","volume":"61","author":"RT Knight","year":"1985","unstructured":"Knight RT, Brailowsky S, Scabini D, Simpson GV (1985). Surface auditory evoked potentials in the unrestrained rat: component definition. Electroencephalogr Clin Neurophysiol 61: 430\u2013439.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"BF1300879_CR22","volume-title":"Histological Processing for the Neural Science","author":"E LaBossiere","year":"1976","unstructured":"LaBossiere E, Glickstein M (1976). Histological Processing for the Neural Science. Charles C Thomas: Springfield."},{"key":"BF1300879_CR23","volume-title":"Inbred Strains Vary for Effects of Acute Ketamine","author":"Y Liang","year":"2004","unstructured":"Liang Y, Trief D, Maxwell CR, Majumdar SM, Majewski-Tiedeken C, Kanes SJ et al (2004). Inbred Strains Vary for Effects of Acute Ketamine. Society for Neuroscience: Washington, DC."},{"key":"BF1300879_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11920-999-0008-y","volume":"1","author":"GA Light","year":"1999","unstructured":"Light GA, Braff DL (1999). Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep 1: 31\u201340.","journal-title":"Curr Psychiatry Rep"},{"key":"BF1300879_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/026988110201600310","volume":"16","author":"MS Man","year":"2002","unstructured":"Man MS, Young AH, McAllister-Williams RH (2002). Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice. J Psychopharmacol 16: 245\u2013252.","journal-title":"J Psychopharmacol"},{"key":"BF1300879_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuroscience.2004.07.038","volume":"129","author":"CR Maxwell","year":"2004","unstructured":"Maxwell CR, Kanes SJ, Abel T, Siegel SJ (2004a). Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. Neuroscience 129: 101\u2013107.","journal-title":"Neuroscience"},{"key":"BF1300879_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.npp.1300376","volume":"29","author":"CR Maxwell","year":"2004","unstructured":"Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE et al (2004b). Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology 29: 739\u2013746.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300879_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00213-001-0996-8","volume":"160","author":"RH McAllister-Williams","year":"2002","unstructured":"McAllister-Williams RH, Rugg MD (2002). Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval. Psychopharmacology (Berl) 160: 74\u201383.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300879_CR29","first-page":"E405","volume":"259","author":"AH Miller","year":"1990","unstructured":"Miller AH, Spencer RL, Stein M, McEwen BS (1990). Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone. Am J Physiol 259: E405\u2013E412.","journal-title":"Am J Physiol"},{"key":"BF1300879_CR30","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1210\/en.2003-1674","volume":"145","author":"NM Morton","year":"2004","unstructured":"Morton NM, Ramage L, Seckl JR (2004). Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145: 2707\u20132712.","journal-title":"Endocrinology"},{"key":"BF1300879_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.psychres.2004.04.001","volume":"127","author":"D Muck-Seler","year":"2004","unstructured":"Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M (2004). Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Res 127: 217\u2013226.","journal-title":"Psychiatry Res"},{"key":"BF1300879_CR32","first-page":"14","volume":"38","author":"C Nemeroff","year":"2004","unstructured":"Nemeroff C (2004). Early-life adversity, CRF dysregulation, and vulnerability to mood and anxiety disorders. Psychopharmacol Bull 38: 14\u201320.","journal-title":"Psychopharmacol Bull"},{"key":"BF1300879_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1440-1819.2000.00741.x","volume":"54","author":"H Ninomiya","year":"2000","unstructured":"Ninomiya H, Sato E, Onitsuka T, Hayashida T, Tashiro N (2000). Auditory P50 obtained with a repetitive stimulus paradigm shows suppression to high-intensity tones. Psychiatry Clin Neurosci 54: 493\u2013497.","journal-title":"Psychiatry Clin Neurosci"},{"key":"BF1300879_CR34","first-page":"57","volume":"45","author":"C Ogura","year":"1991","unstructured":"Ogura C, Nageishi Y, Matsubayashi M, Omura F, Kishimoto A, Shimokochi M (1991). Abnormalities in event-related potentials, N100, P200, P300 and slow wave in schizophrenia. Jpn J Psychiatry Neurol 45: 57\u201365.","journal-title":"Jpn J Psychiatry Neurol"},{"key":"BF1300879_CR35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1388-2457(01)00509-0","volume":"112","author":"Z Pincze","year":"2001","unstructured":"Pincze Z, Lakatos P, Rajkai C, Ulbert I, Karmos G (2001). Separation of mismatch negativity and the N1 wave in the auditory cortex of the cat: a topographic study. Clin Neurophysiol 112: 778\u2013784.","journal-title":"Clin Neurophysiol"},{"key":"BF1300879_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/frne.1996.0143","volume":"18","author":"JR Seckl","year":"1997","unstructured":"Seckl JR (1997). 11beta-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front Neuroendocrinol 18: 49\u201399.","journal-title":"Front Neuroendocrinol"},{"key":"BF1300879_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0920-9964(98)00138-8","volume":"37","author":"AM Shelley","year":"1999","unstructured":"Shelley AM, Silipo G, Javitt DC (1999). Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophr Res 37: 65\u201379.","journal-title":"Schizophr Res"},{"key":"BF1300879_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/sj.npp.1300087","volume":"28","author":"SJ Siegel","year":"2003","unstructured":"Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB et al (2003). Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 28: 675\u2013682.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300879_CR39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuroscience.2005.03.027","volume":"133","author":"SJ Siegel","year":"2005","unstructured":"Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE et al (2005). Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience 133: 729\u2013738.","journal-title":"Neuroscience"},{"key":"BF1300879_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0893-133X(01)00426-2","volume":"26","author":"SJ Siegel","year":"2002","unstructured":"Siegel SJ, Winey KI, Gur RE, Lenox RH, Bilker WB, Ikeda D et al (2002). Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology 26: 817\u2013823.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300879_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0091-3057(01)00523-8","volume":"69","author":"KE Stevens","year":"2001","unstructured":"Stevens KE, Bullock AE, Collins AC (2001). Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacol Biochem Behav 69: 359\u2013366.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300879_CR42","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0006-3223(99)00200-0","volume":"46","author":"KE Stevens","year":"1999","unstructured":"Stevens KE, Kem WR, Freedman R (1999). Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice. Biol Psychiatry 46: 1443\u20131450.","journal-title":"Biol Psychiatry"},{"key":"BF1300879_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0925-4927(01)00113-5","volume":"108","author":"R Tabares-Seisdedos","year":"2001","unstructured":"Tabares-Seisdedos R, Balanza-Martinez V, Pallardo Y, Salazar-Fraile J, Selva G, Vilela C et al (2001). Similar effect of family history of psychosis on Sylvian fissure size and auditory P200 amplitude in schizophrenic and bipolar subjects. Psychiatry Res 108: 29\u201338.","journal-title":"Psychiatry Res"},{"key":"BF1300879_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainres.2004.05.097","volume":"1019","author":"D Umbricht","year":"2004","unstructured":"Umbricht D, Vyssotky D, Latanov A, Nitsch R, Brambilla R, D'Adamo P et al (2004). Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans. Brain Res 1019: 189\u2013200.","journal-title":"Brain Res"},{"key":"BF1300879_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0165-0327(97)00165-1","volume":"48","author":"E Vandoolaeghe","year":"1998","unstructured":"Vandoolaeghe E, van Hunsel F, Nuyten D, Maes M (1998). Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J Affect Disord 48: 105\u2013113.","journal-title":"J Affect Disord"},{"key":"BF1300879_CR46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1037\/0735-7044.109.3.396","volume":"109","author":"JF Willott","year":"1995","unstructured":"Willott JF, Carlson S (1995). Modification of the acoustic startle response in hearing-impaired C57BL\/6J mice: prepulse augmentation and prolongation of prepulse inhibition. Behav Neurosci 109: 396\u2013403.","journal-title":"Behav Neurosci"},{"key":"BF1300879_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0378-5955(99)00003-9","volume":"130","author":"QY Zheng","year":"1999","unstructured":"Zheng QY, Johnson KR, Erway LC (1999). Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130: 94\u2013107.","journal-title":"Hear Res"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300879","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:49:52Z","timestamp":1684219792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,24]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["BF1300879"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300879","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,24]]}}}